Breaking Updates in Hematological-Oncology

The American Society of Hematology (ASH) 2020 Annual Meeting and Exposition was held on the 5–8 December.

Despite the pandemic, the virtual format showcased outstanding leaps in understanding and treatment in 2020, across malignancies.

Explore our coverage by disease type, including updates from key trials in which new agents are moving forwards.

View all videos

ASH 2020

American Society of Hematology (ASH) Annual Meeting and Exposition
5–8 December 2020

Promising findings from the Phase II MAGNOLIA trial of next-gen TKI #Zanubrutinib for R/R marginal zone #Lymphoma

Hear more from @OpatStephen of @MonashUni: http://ow.ly/OyWN50EiVPi

#ASH2020 @ASH_hematology #HemOnc #NonHodgkinLymphoma #Lymsm #CTSM #TrialUpdate

Hugely #inspiring #AACR21 plenary session on #cancer #chromosomal instability and linkage to #immune responses and therapeutic vulnerabilities @AACR David Pellman @Samuel_Bakhoum Stephen Jackson @KarleneCimprich @CharlesSwanton @ZStorchova #CelebrateScience

We can't wait for the next #VJSessions all about the EBMT Trainee Committee!

We are delighted to be joined by @NicoGagelmann @Claire_P_Horgan & @YasSerroukh on 14 April at 1pm EST/7pm CEST

Register here: http://ow.ly/RbO450Ebhc9

@TheEBMT_Trainee @TheEBMT #EBMT21 #OncoAlert

At #AACR21 we spoke w/ Tracy George (@UUtah) on areas of unmet needs for patients with #Mastocytosis

Watch here 👉http://ow.ly/PdoJ50ElliT

@VHemonc @AACR #RareDisease #Mastocytosis #MCAS #MastCellDisease #OncoAlert

Load More...

ASH 2020

American Society of Hematology (ASH) Annual Meeting and Exposition
5–8 December 2020

Breaking Updates in Hematological-Oncology

The American Society of Hematology (ASH) 2020 Annual Meeting and Exposition was held on the 5–8 December.

Despite the pandemic, the virtual format showcased outstanding leaps in understanding and treatment in 2020, across malignancies.

Explore our coverage by disease type, including updates from key trials in which new agents are moving forwards.

View all videos

Promising findings from the Phase II MAGNOLIA trial of next-gen TKI #Zanubrutinib for R/R marginal zone #Lymphoma

Hear more from @OpatStephen of @MonashUni: http://ow.ly/OyWN50EiVPi

#ASH2020 @ASH_hematology #HemOnc #NonHodgkinLymphoma #Lymsm #CTSM #TrialUpdate

Hugely #inspiring #AACR21 plenary session on #cancer #chromosomal instability and linkage to #immune responses and therapeutic vulnerabilities @AACR David Pellman @Samuel_Bakhoum Stephen Jackson @KarleneCimprich @CharlesSwanton @ZStorchova #CelebrateScience

We can't wait for the next #VJSessions all about the EBMT Trainee Committee!

We are delighted to be joined by @NicoGagelmann @Claire_P_Horgan & @YasSerroukh on 14 April at 1pm EST/7pm CEST

Register here: http://ow.ly/RbO450Ebhc9

@TheEBMT_Trainee @TheEBMT #EBMT21 #OncoAlert

At #AACR21 we spoke w/ Tracy George (@UUtah) on areas of unmet needs for patients with #Mastocytosis

Watch here 👉http://ow.ly/PdoJ50ElliT

@VHemonc @AACR #RareDisease #Mastocytosis #MCAS #MastCellDisease #OncoAlert

Load More...

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter